|
| Author | Journal | Date (month/year) | Country | Study type | N | Age | Sex | Quality score | Reference |
|
| Ai et al. | Radiology | Feb/2020 | China | Retrospective cohort | 1014 | 51 ± 15 | M: 467 (46%)
F: 547 (54%) | 10 | [6] |
| Fang et al. | Radiology | Feb/2020 | China | Retrospective cohort | 51 | Median: 45
IQR 39–55 | M: 29 (56.9%)
F: 22 (43.1%) | 10 | [20] |
| Xi et al. | Radiology | Feb/2020 | China | Retrospective cohort | 167 | NR | NR | 10 | [21] |
| Bernheim et al. | Radiology | Feb/2020 | China | Retrospective cohort | 121 | 45.3 ± 16 | M: 61 (50%)
F: 60 (50%) | 12 | [28] |
| Wu et al. | Clinical Infectious Diseases | Feb/2020 | China | Retrospective cohort | 80 | Median: 46.1 | M: 39 (48.7%)
F: 41 (51.3%) | 13 | [29] |
| Chung et al. | Radiology | Feb/2020 | China | Retrospective cohort | 21 | 51 ± 14 | M: 13 (62%)
F: 8 (38%) | 11 | [11] |
| Shi et al. | The Lancet Infectious Diseases | Feb/2020 | China | Retrospective cohort | 81 | 49.5 ± 11 | M: 42 (52%)
F: 39 (48%) | 11 | [14] |
| Yang et al. | Journal of Infection | Feb/2020 | China | Retrospective cohort | 149 | 45.1 ± 13.3 | M: 81 (54.4%)
F: 68 (45.6%) | 12 | [24] |
| Guan et al. | New England Journal of Medicine | Feb/2020 | China | Retrospective cohort | 1099 | Median: 47
IQR 35-58 | M: 639 (58.1%)
F: 460 (41.9%) | 13 | [31] |
| Cheng et al. | American Journal of Roentgenology | Feb/2020 | China | Retrospective cohort | 33
11+ve COVID-19
22 Non -COVID | 50.36 ± 15.5 for cases | M: 8 (72.7%)
F: 3 (27.3%) | 10 | [12] |
| Huang et al. | The Lancet Infectious diseases | Feb/2020 | China | Prospective cohort | 41 | Median: 40
IQR 41-58 | M: 30 (73.2%)
F: 11 (26.8%) | 12 | [13] |
| Long et al. | European Journal of Radiology | March/2020 | China | Case control study | 87
Cases: 36
Control: 51 | 44.8 ± 18.2 for cases | Cases: 36
M: 20 (55.6%)
F: 16 (44.4%) | 10 | [22] |
| Himoto et al. | Japanese Journal of Radiology | March/2020 | Japan | Retrospective cohort | 21 (cases: 6, others: 15) | Median: 58.5
Range (45–81) for 6 cases | M: 5 (83.3%)
F: 1 (16.7%) | 10 | [18] |
| Zhang et al. | European Respiratory Journal | March/2020 | China | Retrospective cohort | 17 | Median: 48.6
Range (23–74) | M: 8 (47%)
F: 9 (53%) | 11 | [19] |
| Xu et al. | International Journal of Infectious Diseases | March/2020 | China | Retrospective cohort | 51 | NR | M: 25 (49%)
F: 26 (51%) | 10 | [26] |
| Guan et al. | Academic Radiology | March/2020 | China | Retrospective cohort | 53 | 42 | M: 25 (47.2%)
F: 28 (52.8%) | 10 | [27] |
| Caruso et al. | Radiology | April/2020 | Italy | Prospective cohort | 158 | 57 ± 17 | M: 83 (52.5%)
F: 75 (47.5%) | 12 | [25] |
| Wang et al. | International Journal of Infectious Diseases | April/2020 | China | Retrospective cohort | 125 | 41.46 ± 15 | M: 71 (56.8%)
F: 54 (43.2%) | 10 | [30] |
| Meng et al. | Journal of Infection | April/2020 | China | Retrospective cohort | 58 | 42.6 ± 16.5 | M: 26 (44.8%)
F: 32 (55.2%) | 11 | [17] |
| Zhifeng et al. | Journal of Clinical Virology | April/2020 | China | Retrospective cohort | 69 | Range (23–82) | M: 41 (59.4%)
F: 28 (40.6%) | 9 | [32] |
| Xia et al. | Journal of Clinical Virology | April/2020 | China | Retrospective cohort | 10 | 56.5 ± 11.16 | M: 4 (40%)
F:6 (60%) | 10 | [15] |
| Dai et al. | International Journal of Infectious Diseases | April/2020 | China | Retrospective cohort | 234 | 44.6 ± 14.8 | M: 136 (58.1%)
F: 98 (41.9%) | 12 | [33] |
| Ding et al. | European Journal of Radiology | April/2020 | China | Retrospective cohort | 112 | 55.8 ± 16.1 | M: 51 (45.5%)
F: 61 (54.5%) | 11 | [34] |
| Hu et al. | European Journal of Radiology | April /2020 | China | Retrospective cohort | 46 | 39.2 ± 9.6 Range (23–60) | M: 27 (58.7%)
F: 19 (41.3%) | 10 | [35] |
| Wang et al. | Clinical Radiology | May/2020 | China | Retrospective cohort | 114 | Median: 53
Range (23–78) | M: 56 (49.1%)
F: 58 (50.9%) | 11 | [23] |
| Li et al. | Journal of Clinical Virology | June/2020 | China | Retrospective cohort | 225 | 50 ± 14 | M: 120 (53.3%)
F: 105 (46.7%) | 10 | [16] |
|
